Pneumococcal (PCV / PPSV)

Pneumococcal disease is caused by Streptococcus pneumoniae, a bacterium capable of invading organs beyond the lungs. It is a leading cause of pneumonia, meningitis, and sepsis, particularly in young children, older adults, and individuals with weakened immunity. Vaccines such as conjugate (PCV) and polysaccharide (PPSV) types protect against multiple S. pneumoniae serotypes. Proper immunisation reduces the risk of serious disease, hospitalisation, and death, making it a cornerstone of preventive healthcare.

The Pneumococcal Vaccine helps prevent:

• Invasive pneumococcal disease (meningitis, bacteraemia)
• Pneumococcal pneumonia
• Sepsis caused by S. pneumoniae
• Severe complications in high-risk groups (chronic lung, heart, or immune conditions)

• Lowers the risk of serious pneumococcal infections and their complications
• Reduces hospitalisations and mortality due to pneumonia, meningitis, and sepsis
• Modern vaccines such as Prevenar 13 and Pneumovax 23 offer broader serotype coverage.
• Recommended by major public health authorities, including the CDC and WHO, for children and high-risk adults
• Helps protect vulnerable populations through herd immunity
• A cost-effective preventive strategy that reduces the long-term disease burden

Pneumococcal vaccines for adults are generally well tolerated. Common side effects include:

Severe allergic reactions are very rare and are promptly managed under medical supervision.

The safety precautions patients need to follow before receiving the pneumococcal vaccine for adults:

• Inform your doctor if you have a history of severe allergic reactions to vaccines.
• Defer vaccination during moderate or severe acute illness.
• Mild ailments such as colds usually do not require postponement.
• Stay well hydrated and eat a light meal before vaccination.
• Wear clothing that allows easy access to the upper arm (deltoid area).
• Remain under observation for about 15 minutes after vaccination to monitor for any immediate reactions.